Anpario plc (LON:ANP – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of GBX 516.89 and traded as low as GBX 506. Anpario shares last traded at GBX 516.17, with a volume of 10,826 shares trading hands.
Analyst Ratings Changes
Several analysts have recently weighed in on ANP shares. Canaccord Genuity Group increased their price target on shares of Anpario from GBX 570 to GBX 600 and gave the company a “buy” rating in a research note on Friday, September 11th. Shore Capital Group reaffirmed a “house stock” rating on shares of Anpario in a research report on Monday, August 17th. One analyst has rated the stock with a Buy rating. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of GBX 600.
Check Out Our Latest Stock Analysis on ANP
Anpario Trading Up 0.8%
The business has a fifty day moving average price of GBX 506.33 and a two-hundred day moving average price of GBX 516.89. The company has a current ratio of 6.29, a quick ratio of 5.16 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of £83.99 million, a PE ratio of 13.10 and a beta of 1.05.
Anpario (LON:ANP – Get Free Report) last issued its quarterly earnings data on Wednesday, September 9th. The company reported GBX 22.45 earnings per share (EPS) for the quarter. Anpario had a net margin of 14.53% and a return on equity of 17.05%. Analysts expect that Anpario plc will post 23.58 EPS for the current fiscal year.
Anpario Company Profile
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Further Reading
- Five stocks we like better than Anpario
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.
